October 11, 2022 Issue of JAMA

October 11, 2022, Vol 328, No. 14, Pages 1381-1470

This Week in JAMA

Audio Highlights

Abstract Full Text

free access online only has audio

JAMA. 2022;328(14):e2117164. doi:10.1001/jama.2021.17164

Podcast: Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Original Investigation

Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes

Dan-Yu Lin, PhD; Yu Gu, BS; Yangjianchen Xu, BS; et al.

Abstract Full Text

free access has active quiz

JAMA. 2022;328(14):1415-1426. doi:10.1001/jama.2022.17876

This study uses data from March 2020 to June 2022 to examine the association of the primary and booster COVID-19 vaccines with SARS-CoV-2 infection, hospitalization, and death.

Editorial
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection
Mark W. Tenforde, MD, PhD; Ruth Link-Gelles, PhD; Manish M. Patel, MD

JAMA

Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines

J. Daniel Kelly, MD, PhD; Samuel Leonard, MS; Katherine J. Hoggatt, PhD; et al.

Abstract Full Text

free access has active quiz

JAMA. 2022;328(14):1427-1437. doi:10.1001/jama.2022.17985

This retrospective cohort study assesses incidence of breakthrough COVID-19 and hospitalization with COVID-19 pneumonia or death among adults who received a vaccination series plus 1 booster against SARS-CoV-2.

Preliminary Communication

Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical Trial

Jeffry Florian, PhD; Rutger van der Schrier, MD; Victoria Gershuny, PhD; et al.

Abstract Full Text

free access

JAMA. 2022;328(14):1405-1414. doi:10.1001/jama.2022.17735

This clinical trial assesses whether paroxetine plus oxycodone or quetiapine plus oxycodone combinations decreased the ventilatory response to hypercapnia compared with oxycodone alone.

Research Letter

Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada

Colleen Webber, PhD; Daniel T. Myran, MD, MPH; Christina Milani, MSc; et al.

Abstract Full Text

free access has active quiz

JAMA. 2022;328(14):1456-1458. doi:10.1001/jama.2022.17214

This study examines the incidence of cognitive decline among long-term care residents in Ontario before and during the COVID-19 pandemic.

Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares

April M. Jorge, MD; Christian Mancini, BS; Baijun Zhou, MS; et al.

Abstract Full Text

free access

JAMA. 2022;328(14):1458-1460. doi:10.1001/jama.2022.13591

This study of an academic medical center patient cohort with systemic lupus erythematosus (SLE) investigates the association between hydroxychloroquine dose based on current guidelines and risk of lupus flares.

US Preventive Services Task Force

Recommendation Statement

Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

Abstract Full Text

free access has active quiz has audio

JAMA. 2022;328(14):1438-1444. doi:10.1001/jama.2022.16936

This 2022 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety in children and adolescents aged 8 to 18 years (B recommendation) and concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger (I statement).

Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Editorial
Screening for Pediatric Anxiety Disorders
John T. Walkup, MD; Cori M. Green, MD, MSc; Jeffrey R. Strawn, MD

JAMA
- Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Evidence Report

Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force

Meera Viswanathan, PhD; Ina F. Wallace, PhD; Jennifer Cook Middleton, PhD; et al.

Abstract Full Text

free access has active quiz has audio

JAMA. 2022;328(14):1445-1455. doi:10.1001/jama.2022.16303

This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on screening for anxiety in children and adolescents summarizes published evidence on the benefits and harms of screening for and treatment of anxiety in children and adolescents 18 years or younger.

Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Editorial
Screening for Pediatric Anxiety Disorders
John T. Walkup, MD; Cori M. Green, MD, MSc; Jeffrey R. Strawn, MD

JAMA
- Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Viewpoint

Unsettled Liability Issues for 鈥淧rediagnostic鈥� Wearables and Health-Related Products

David A. Simon, JD, LLM, PhD; Carmel Shachar, JD, MPH; I. Glenn Cohen, JD

Abstract Full Text

JAMA. 2022;328(14):1391-1392. doi:10.1001/jama.2022.16317

This Viewpoint examines the murky legal treatment of various health-related wearable or other general wellness products for patients, physicians, and manufacturers, and recommends solutions.

Social Media and Medical Misinformation: Confronting New Variants of an Old Problem

Dhruv Khullar, MD, MPP

Abstract Full Text

has audio

JAMA. 2022;328(14):1393-1394. doi:10.1001/jama.2022.17191

This Viewpoint describes several proposals to mitigate the role of social media in medical misinformation from the ABIM Foundation鈥檚 2022 Forum, including algorithmic adjustment, misinformation research and surveillance, and medical professional training and community engagement.

Podcast: Social Media and Medical Misinformation: Confronting New Variants of an Old Problem

Disaggregation of Race and Ethnicity Group Data: Research-to-Practice Issues in Clinical Environments

Farah Kader, MPH; Perla Chebli, MPH, PhD

Abstract Full Text

JAMA. 2022;328(14):1395-1396. doi:10.1001/jama.2022.17194

This Viewpoint discusses the importance of accurately categorizing and collecting race and ethnicity data, matching self-identity with race and ethnicity labels, in an effort to quantify the extent of health disparities.

A Piece of My Mind

Erasing Shame in Sexuality

Eric Kutscher, MD

Abstract Full Text

free access

JAMA. 2022;328(14):1397-1398. doi:10.1001/jama.2022.17156

In this narrative medicine essay, an addiction medicine fellow鈥檚 encounter with a man feeling shame for contracting monkeypox reaffirms his initial desire to pursue medicine鈥攖o 鈥渉elp eradicate prejudice in health care.鈥�

Editorial

Screening for Pediatric Anxiety Disorders

John T. Walkup, MD; Cori M. Green, MD, MSc; Jeffrey R. Strawn, MD

Abstract Full Text

has audio

JAMA. 2022;328(14):1399-1401. doi:10.1001/jama.2022.15224

Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Long-term Protection Associated With COVID-19 Vaccination and Prior Infection

Mark W. Tenforde, MD, PhD; Ruth Link-Gelles, PhD; Manish M. Patel, MD

Abstract Full Text

free access

JAMA. 2022;328(14):1402-1404. doi:10.1001/jama.2022.14660

Medical News & Perspectives

Quick Uptakes

New Guidance From the American Academy of Pediatrics on Protecting Children From Sexual Abuse in Health Care Settings

Melissa Suran, PhD, MSJ

Abstract Full Text

has audio

JAMA. 2022;328(14):1385-1386. doi:10.1001/jama.2022.16787

This Medical News article discusses a new policy statement from the American Academy of Pediatrics on preventing and responding to pediatric sexual abuse in health care settings.

Podcast: September 2022 Medical News Summary

News From the Centers for Disease Control and Prevention

Lowest US Life Expectancy Since 1996 Linked to COVID-19

Bridget M. Kuehn, MSJ

Abstract Full Text

free access

JAMA. 2022;328(14):1389. doi:10.1001/jama.2022.15455

Catch-up Vaccinations Needed for Some Adolescents

Bridget M. Kuehn, MSJ

Abstract Full Text

JAMA. 2022;328(14):1389-1390. doi:10.1001/jama.2022.15454

Identifying False-Positive Monkeypox Results

Bridget M. Kuehn, MSJ

Abstract Full Text

free access

JAMA. 2022;328(14):1390. doi:10.1001/jama.2022.16814

Biotech Innovations

Progress on Replication-Defective Live Virus Vaccines

Howard D. Larkin

Abstract Full Text

JAMA. 2022;328(14):1387. doi:10.1001/jama.2022.15450

Trial Tests Combined Cell and Gene Therapy for ALS

Howard D. Larkin

Abstract Full Text

JAMA. 2022;328(14):1387. doi:10.1001/jama.2022.15449

Open-source Closed-Loop System Is Effective for Type 1 Diabetes

Howard D. Larkin

Abstract Full Text

JAMA. 2022;328(14):1387-1388. doi:10.1001/jama.2022.15451

Poetry and Medicine

Dona Nobis Pacem

Adrian M. Schnall, MD

Abstract Full Text

JAMA. 2022;328(14):1464. doi:10.1001/jama.2022.12774

JAMA Revisited

Rest

Abstract Full Text

JAMA. 2022;328(14):1465. doi:10.1001/jama.2021.17165

JAMA Patient Page

Screening for Anxiety in Children and Adolescents

Jill Jin, MD, MPH

Abstract Full Text

free access has audio

JAMA. 2022;328(14):1469-1470. doi:10.1001/jama.2022.18184

This JAMA Patient Page summarizes the US Preventive Services Task Force鈥檚 recent recommendations on screening for anxiety in children and adolescents.

Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Editorial
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection
Mark W. Tenforde, MD, PhD; Ruth Link-Gelles, PhD; Manish M. Patel, MD

JAMA
Screening for Pediatric Anxiety Disorders
John T. Walkup, MD; Cori M. Green, MD, MSc; Jeffrey R. Strawn, MD

JAMA
- Podcast: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents

Comment & Response

Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant

Chi-Kuei Hsu, MD; Chih-Cheng Lai, MD

Abstract Full Text

JAMA. 2022;328(14):1460. doi:10.1001/jama.2022.14481

Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant鈥擱eply

Vajeera Dorabawila, PhD; Mary T. Bassett, MD; Eli S. Rosenberg, PhD

Abstract Full Text

JAMA. 2022;328(14):1460-1461. doi:10.1001/jama.2022.14484

Physician Adenoma Detection Rates and Colorectal Cancer

Edwin Colloff, MD

Abstract Full Text

JAMA. 2022;328(14):1461. doi:10.1001/jama.2022.14308

Physician Adenoma Detection Rates and Colorectal Cancer

Michael J. Schell, PhD; Clement K. Gwede, PhD; Mark Friedman, MD

Abstract Full Text

JAMA. 2022;328(14):1462. doi:10.1001/jama.2022.14311

Physician Adenoma Detection Rates and Colorectal Cancer鈥擱eply

Douglas A. Corley, MD, PhD; Joanne Schottinger, MD; Christopher Jensen, PhD

Abstract Full Text

JAMA. 2022;328(14):1462-1463. doi:10.1001/jama.2022.14314

Correction

Incorrect Information

Abstract Full Text

free access

JAMA. 2022;328(14):1463. doi:10.1001/jama.2022.18012

November 2024 - July 1883

Decade

Year

Issue

October 11, 2022, Vol 328, No. 14, Pages 1381-1470

Recommendation Statement

Evidence Report

Quick Uptakes

Latest from the USPSTF